Thyroid and Fat Tissue Metabolism
NCT00312715 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41
Last updated 2017-10-06
Summary
This study will use a technique called microperfusion to examine how thyroid hormones are involved in fat metabolism. The thyroid gland produces two kinds of hormones: T3 and T4. Some of the T4 is changed to T3 in various organs after leaving the thyroid. The T3 stimulates the body to burn fat. People have different rates at which they can change T4 to T3, and this may lead to differences in body fat among different people.
Microperfusion is based on the exchange of substances across tiny holes of a small plastic tube called a "probe," which is inserted after numbing the skin over a fat pad. Through these openings, the fat pad is continuously rinsed with small amounts of fluid, and an exchange of substances occurs. The fluid drips from the other opening of the probe and is collected in a vial. Small amounts of study drugs are infused and the amount of substances released by the fat pad in response to them are measured.
Healthy normal volunteers 18 years of age and older may be eligible for this study. Candidates are screened with a medical history, physical examination and blood tests.
Participants undergo microperfusion. A needle is placed in an arm vein for collecting blood samples before and at the end of the experiment for measuring thyroid hormones and other substances in the blood. The skin over the fat pad next to the umbilicus (navel) is numbed and two microperfusion probes are inserted. A salt water solution is infused into the fat pad for one hour and the substances in the fluid are measured as the fluid leaves the fat pad. After 1 hour isoproterenol, a drug that aids in energy production by fat, is added to help determine the level of fat metabolism. After an additional hour small amounts of thyroid hormone are added to the fluid and samples are collected as they leave the body. Two catheters are inserted during each experiment. Small volumes of sterile fluid are circulated continuously in the tubing and samples are collected at regular intervals.
Conditions
- Healthy Volunteers
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
lead NIH
Principal Investigators
-
Francesco S Celi, M.D. · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-04-03
- Completion
- 2014-07-08
Countries
- United States
Study Locations
More Related Trials
-
Effects of Hyperthyroidism on Amount and Activity of Brown Adipose Tissue
NCT02133040 ·Status: UNKNOWN
-
Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment
NCT01441154 ·Status: COMPLETED
-
The Role of Thyroid Status in Regulating Brown Adipose Tissue Activity, White Adipose Tissue Partitioning and Resting Energy Expenditure
NCT03064542 ·Status: COMPLETED
-
Thyroid Study Type 2 Diabetes Mellitus (T2DM)
NCT01379170 ·Status: UNKNOWN ·Phase: PHASE4
-
Desiccated Thyroid Extract Versus Synthetic T3/T4 Combination (ThyrolarTM) Versus L-T4 Alone in the Therapy of Primary Hypothyroidism With Special Attention to the Gene Polymorphism
NCT02317926 ·Status: UNKNOWN ·Phase: NA
-
Digital Lifestyle Management for Weight Loss Control After Thyroidectomy in Thyroid Cancer Patients
NCT05126706 ·Status: UNKNOWN ·Phase: NA
-
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
NCT03841617 ·Status: RECRUITING ·Phase: PHASE2
-
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3
NCT00812149 ·Status: COMPLETED
-
Natural History of Thyroid Function Disorders
NCT00001159 ·Status: RECRUITING
-
Thyromental Height Test (TMHT) as a Predictor of Difficult Airway in Obese Patients
NCT04212156 ·Status: COMPLETED
-
ThyrOp: A Study of Individual Subclinical Hypothyroidism After Hemithyroidectomy for Benign Nontoxic Goiter
NCT01358136 ·Status: UNKNOWN
-
Studies on Tumors of the Thyroid
NCT00001160 ·Status: RECRUITING
-
Metabolomics of Thyroid Hormones
NCT03823859 ·Status: COMPLETED
-
Brown Adipose Tissue Activity and Thyroid Hormone
NCT02499471 ·Status: COMPLETED ·Phase: NA
-
Differentiation of Benign From Malignant Thyroid Nodules Using Diffuse Reflectance Spectroscopy
NCT07124065 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
NCT00054756 ·Status: COMPLETED ·Phase: PHASE2
-
Hypothyroidism, Metabolism and Quality of Life - Focus on QOL, REE, Cognitive Function and Body Composition
NCT02891668 ·Status: COMPLETED
-
Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration
NCT00196729 ·Status: COMPLETED ·Phase: PHASE3
-
A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours
NCT01736163 ·Status: COMPLETED
-
Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid
NCT05501041 ·Status: ENROLLING_BY_INVITATION
-
PET Evaluation of Recurrent Differentiated Thyroid Cancer
NCT01641679 ·Status: UNKNOWN
-
A Study of Sustained-Release Liothyronine Sodium (T3) in Healthy Subjects
NCT01581463 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism
NCT00531713 ·Status: COMPLETED ·Phase: PHASE4
-
Thyroid Disease Serum Repository
NCT00592605 ·Status: COMPLETED
-
The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients
NCT00080574 ·Status: COMPLETED ·Phase: PHASE2